Skip to main content

RHUMBLINE ADVISERS

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in LENZ

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$137,137
-$68,518 QoQ
Shares Held
24,144
+7.4% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 143 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in LENZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. LENZ ranks #264 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LENZ

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $137,137 24,144
2026-03-31 $205,655 22,476
2025-12-31 $324,000 20,250
2025-09-30 $1,165,385 25,019
2025-06-30 $714,079 24,363
2025-03-31 $461,931 17,967
2024-12-31 $541,427 18,754
2024-09-30 $419,105 17,654
2024-06-30 $290,679 16,812
2024-03-31 $102,673 4,598
2023-12-31 GRPH 31,202
2023-09-30 GRPH 33,711
2023-06-30 GRPH 29,094
2022-03-31 GRPH 24,660
2021-12-31 GRPH 11,686
2021-09-30 GRPH 11,746